DLK1 and hepatocellular carcinoma: Serum AFP is a widely used hepatocellular carcinoma (HCC) biomarker and, in the Afphi branch 1, we identified an intermediate cellular state, largely corresponding to the Dlk1+/Gpc3+ ‘hepatoblastic cluster’ (Fig. 3h, bottom).